New Federally Funded Study Links Medical Cannabis to Reduced Anxiety and Depression

At a time when millions are seeking safer, more natural tools to manage mental health, a new study published in the Journal of Affective Disorders offers encouraging news. Backed by funding from the National Institute on Drug Abuse (NIDA), the study found that medical cannabis use was associated with clinically significant reductions in both anxiety and depression among adults in Maryland.

The research followed 33 participants over a six-month period, assessing their mental health at four intervals: baseline, 1 month, 3 months, and 6 months after beginning medical cannabis treatment. By the three-month mark, most participants had already experienced notable relief, and those benefits persisted through the remainder of the study. Nearly all patients in the study selected THC-dominant products, often via oral dosing or vaporization.

In addition to mood improvement, participants reported enhanced sleep and quality of life. However, researchers also documented increased intoxication and a temporary drop in driving confidence—effects that were dose-dependent and highlight the importance of mindful, informed cannabis use.

“This research helps bring credibility and clarity to what many in the cannabis community have known intuitively,” said Dr. Dana Lillestol, PhD, Senior Education Advisor and Chill Pill Advocate at Life Is Chill. “When used responsibly and with intention, medical cannabis can offer real relief to those living with anxiety and depression. It’s not about escaping reality—it’s about finding a grounded, plant-based path to emotional resilience.”

The study was led by a collaborative team from Johns Hopkins University School of Medicine, Johns Hopkins Bloomberg School of Public Health, and the Centre for Alcohol Policy Research in Melbourne, Australia. It was additionally supported by a grant from the Lambert Center at Thomas Jefferson University, alongside NIDA funding.

Researchers emphasized that while the findings are promising, more rigorous clinical trials are still needed to fully validate cannabis as a treatment pathway for mood disorders. But for patients and practitioners alike, this marks an important step toward integrating cannabis into evidence-based mental health care.

At Life Is Chill, we’re proud to champion products that reflect this new era of informed, wellness-driven cannabis use. From precision-dosed Chill Pills to fast-acting Chill Drops, our offerings are designed to support a balanced, mindful lifestyle—grounded in science and powered by calm.

 

Scroll to Top